Private Equity
The firm sees opportunities at the intersection of energy and Europe’s push for greater sovereignty, IR head Cenk Turkinan tells PEI.
3 min read · 16 March 2026
Announcing the winners of PE Hub’s Deal of the Year Awards for 2025, in which Blackstone, Carlyle and Hellman & Friedman took home the top honor for Medline’s $7.2bn IPO.
4 min read · 16 March 2026
'No other fund understood the value chain of selling through the automotive manufacturer selling through their network. We did,' Tom Tuttle, chairman, Kinderhook, told PE Hub.
3 min read · 16 March 2026
'When we came into the deal, we allowed Medline to tap for the first time into the US debt markets, including the leveraged loan and high-yield market,' Robert Schmidt, partner, Carlyle, told PE Hub.
3 min read · 16 March 2026
'I'm sure there will be a lot of movement going forward and continuing the path which we have opened,' Ilinca Rosetti, operating partner, JC Flowers, told PE Hub.
3 min read · 16 March 2026
'We saw a solid foundation to build on, particularly in pens and calendars, and an opportunity to broaden the company’s hard goods offering,' Jonathan Fox, managing director, HIG, told PE Hub.
3 min read · 16 March 2026
'We had one of the largest legal databases in the world, and a tool that can use this data to make lawyers more productive,' Valero Domingo, partner, Oakley, told PE Hub.
3 min read · 16 March 2026
'We’ve been investing in AI for years and our CTO at SmartComms was one of the best we had worked with. We were confident that we were on the front foot,' Maurice Hernandez, managing director, Accel-KKR, told PE Hub.
3 min read · 16 March 2026
Norvestor has agreed terms for a NKr2.2 billion ($225 million; €197 million) offer for Oslo-listed Zalaris, a payroll and HR services provider.
3 min read · 16 March 2026
Highlighting how various subsegments of the women’s health market have caught the eye of private equity firms such as Ardian, CVC and Verdane; a look at Excellere Partners and GHO Capital Partners’ $950 million agreement to sell a pathology services company to Agilent Therapeutics; new appointments announced by Vistria.
4 min read · 13 March 2026